keyword
https://read.qxmd.com/read/38626998/top-studies-of-2023-relevant-to-primary-care-from-the-peer-team
#1
REVIEW
Betsy S Thomas, Danielle Perry, Samantha S Moe, Ricky D Turgeon, Jen Potter, Émélie Braschi, Nicholas Dugré, Jessica E M Kirkwood, G Michael Allan
OBJECTIVE: To provide a summary of the noteworthy medical articles published in 2023 that are relevant to family physicians. SELECTING THE EVIDENCE: Articles were chosen and ranked by the PEER (Patients, Experience, Evidence, Research) team, a group of primary care health professionals focused on evidence-based medicine. The selection process involved routine surveillance of tables of contents in high-impact medical journals and continuous monitoring of EvidenceAlerts...
April 2024: Canadian Family Physician Médecin de Famille Canadien
https://read.qxmd.com/read/38511397/the-thiazide-like-diuretic-chlorthalidone-as-an-alternative-evidence-based-therapy-for-resistant-hypertension-in-patients-with-stage-4-chronic-kidney-disease
#2
EDITORIAL
Panagiotis I Georgianos, Vasilios Vaios, Ioannis Kontogiorgos, Maria Divani, Vassilios Liakopoulos
No abstract text is available yet for this article.
March 22, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38482311/hyponatremia-induced-worsening-of-trigeminal-neuralgia-when-the-sodium-plays-the-game
#3
Mohammad Z Ansari, Rashmi Singh, Bijaya Mohanty, Sarita Kumari, Ashok Sunder
A 78-year-old elderly male who was on treatment for trigeminal neuralgia and hypertension was brought to the emergency with altered sensorium. His vital parameters were within normal limits; however, the arterial blood gas analysis showed severe hyponatremia. He was admitted to the ward, where further workup was carried out and hyponatremia correction started. He had a sudden worsening in his facial pain before he landed in encephalopathy. His medications (oxcarbazepine and chlorthalidone) that could cause hyponatremia were stopped, and judicious correction of hyponatremia was done...
January 2024: Journal of Family Medicine and Primary Care
https://read.qxmd.com/read/38466351/a-design-of-experiment-based-rp-hplc-method-for-the-simultaneous-estimation-of-antihypertensive-drugs-with-greenness-assessment
#4
JOURNAL ARTICLE
Naveenarani Dharuman, Lakshmi Karunanidhi Santhana, Manikandan Krishnan
The correlation between blood pressure (BP) and cardiovascular risk has a continuous, positive, and linear pattern. Lowering high BP decreases the risk associated with cardiovascular disease. Chlorthalidone (CHD) and Losartan potassium (LOS) combination is used to treat hypertension. The analytical community was concerned with minimizing or reducing the use of toxic chemicals and solvents. Therefore, the current study aimed to develop a rapid, sensitive, and cost-effective green RP-HPLC method to determine CHD and LOS simultaneously in a short analysis of time...
March 11, 2024: Analytical Sciences: the International Journal of the Japan Society for Analytical Chemistry
https://read.qxmd.com/read/38374541/elimination-profile-of-low-dose-chlortalidone-and-its-detection-in-hair-for-doping-analysis-implication-for-unintentional-non-therapeutic-exposure
#5
JOURNAL ARTICLE
Detlef Thieme, Kai Weigel, Patricia Anielski, Aniko Krumbholz, Frank Sporkert, Annekathrin M Keiler
Chlortalidone (CLT) is a thiazide-type diuretic with high affinity for the erythrocyte carbonic anhydrase. Therapeutically, it is mostly used to treat edema and hypertension due to liver cirrhosis, heart insufficiency, or renal dysfunction. Although diuretics and masking agents are prohibited by the World Anti-Doping Agency (WADA) at all times in sports, substances belonging to this category are constantly detected in athlete samples, according to WADA's annual testing figures. Within this group of structurally diverse compounds, a threshold of 20 ng/mL has been introduced for six substances solely due to their presence as contaminants in other permitted drugs because of pharmaceutical production processes...
February 19, 2024: Drug Testing and Analysis
https://read.qxmd.com/read/38353215/circulating-microrna-biomarkers-of-thiazide-response-in-hypertension
#6
JOURNAL ARTICLE
Lakshmi Manasa S Chekka, Marwa Tantawy, Taimour Langaee, Danxin Wang, Rolf Renne, Arlene B Chapman, John G Gums, Eric Boerwinkle, Rhonda M Cooper-DeHoff, Julie A Johnson
BACKGROUND: Thiazide diuretics are the second most frequently prescribed class of antihypertensives, but up to 50% of patients with hypertension have minimal antihypertensive response to thiazides. We explored circulating microRNAs (miRNAs) in search of predictive biomarkers of thiazide response. METHODS AND RESULTS: We profiled 754 miRNAs in baseline plasma samples of 36 hypertensive European American adults treated with hydrochlorothiazide, categorized into responders (n=18) and nonresponders (n=18) on the basis of diastolic blood pressure response to hydrochlorothiazide...
February 14, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38204501/diuretic-strategies-in-acute-decompensated-heart-failure-a-narrative-review
#7
REVIEW
Ben J Wilson, Duane Bates
BACKGROUND: Heart failure is a common condition with considerable associated costs, morbidity, and mortality. Patients often present to hospital with dyspnea and edema. Inadequate inpatient decongestion is an important contributor to high readmission rates. There is little evidence concerning diuresis to guide clinicians in caring for patients with acute decompensated heart failure. Contemporary diuretic strategies have been defined by expert opinion and older landmark clinical trials...
2024: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/38045916/the-18-year-risk-of-cancer-angioedema-insomnia-depression-and-erectile-dysfunction-in-association-with-antihypertensive-drugs-post-trial-analyses-from-allhat-medicare-linked-data
#8
JOURNAL ARTICLE
Xianglin L Du, Journey Martinez, Jose-Miguel Yamal, Lara M Simpson, Barry R Davis
PURPOSE: This study aimed to determine the 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drug use. METHODS: This is a post-trial passive follow-up study of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants between 1994 and 1998 that was conducted by linking their follow-up data with Medicare claims data until 2017 of subjects who were free of outcomes at baseline on 1 January 1999...
2023: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/37965736/use-trends-of-chlorthalidone-and-hydrochlorothiazide-among-united-states-adults-with-hypertension-national-health-and-nutrition-examination-survey-2009-2018
#9
JOURNAL ARTICLE
Genevieve Hale, Emily Puchades, Gema Jacomino, Layall El-Mcharfie, Alexandra Perez
OBJECTIVES: To estimate the national prevalence of chlorthalidone and hydrochlorothiazide use among adults diagnosed with hypertension by sociodemographic subgroup, healthcare access status, and clinical factors. METHODS: Data was extracted from the National Health and Nutrition Examination Survey for 2009-2010 through 2017-2018 survey waves. Patients at least 20 years old, diagnosed with hypertension, and on hydrochlorothiazide or chlorthalidone were included...
November 16, 2023: Journal of Hypertension
https://read.qxmd.com/read/37909173/chlorthalidone-or-spironolactone-for-patients-with-trh-and-advanced-chronic-kidney-disease
#10
JOURNAL ARTICLE
Bertram Pitt, Richard J Auchus
No abstract text is available yet for this article.
November 1, 2023: Hypertension
https://read.qxmd.com/read/37908922/chlorthalidone-induced-fixed-drug-eruption-unmasking-an-uncommon-reaction-to-a-common-diuretic
#11
Mariana Marrero Castillo, David Kaufman, Juanita Valdes Camacho, Kesler Bourgoyne, John Jacob, Benedict Amalraj, Neerja Gulati
Fixed-drug eruptions (FDEs) are dermatological reactions characterized by specific skin lesions triggered by certain medications. Our case reports commonly used medications that can cause drug-induced skin reactions. Chlorthalidone, a widely used diuretic, had not been prominently linked to FDEs. Here, we present the case of a 45-year-old African-American male who developed classic FDE skin lesions following the initiation of chlorthalidone therapy. This case underscores the imperative for further investigation and heightened awareness among healthcare professionals regarding chlorthalidone-associated FDEs...
September 2023: Curēus
https://read.qxmd.com/read/37855647/-chlorthalidone-or-hydrochlorothiazide-as-the-first-choice-in-the-treatment-of-people-with-hypertension
#12
JOURNAL ARTICLE
Johann Steurer
No abstract text is available yet for this article.
August 2023: Praxis
https://read.qxmd.com/read/37846572/potassium-magnesium-citrate-is-superior-to-potassium-chloride-in-reversing-metabolic-side-effects-of-chlorthalidone
#13
JOURNAL ARTICLE
Wanpen Vongpatanasin, John M Giacona, Danielle Pittman, Ashley Murillo, Ghazi Khan, Jijia Wang, Talon Johnson, Jimin Ren, Orson Moe, Charles C Y Pak
BACKGROUND: Thiazide diuretics (TD) are the first-line treatment of hypertension because of its consistent benefit in lowering BP and cardiovascular risk. TD is also known to cause an excess risk of diabetes, which may limit long-term use. Although potassium (K) depletion was thought to be the main mechanism of TD-induced hyperglycemia, TD also triggers magnesium (Mg) depletion. However, the role of Mg supplementation in modulating metabolic side effects of TD has not been investigated...
October 17, 2023: Hypertension
https://read.qxmd.com/read/37761849/identification-of-long-non-coding-rna-profiles-and-potential-therapeutic-agents-for-fibrolamellar-carcinoma-based-on-rna-sequencing-data
#14
JOURNAL ARTICLE
Janghyun Kim, Young Kim, Bora Lee
BACKGROUND: Fibrolamellar carcinoma (FLC) is a rare type of liver cancer that primarily affects adolescents and young adults without prior liver disease or viral infections. Patients with FLC generally have non-specific symptoms, are often diagnosed at a later stage, and experience a higher frequency of metastases compared to patients with other liver cancers. A fusion transcript of DNAJB1 and PRKACA, which can lead to increased activity of PKA and cellular proliferation, has been identified in all FLC patients, but the exact mechanism through which FLC develops remains unclear...
August 28, 2023: Genes
https://read.qxmd.com/read/37747353/central-composite-design-expert-supported-rp-hplc-optimization-and-quantitative-evaluation-of-efonidipine-hydrochloride-ethanolate-chlorthalidone-in-tablet
#15
JOURNAL ARTICLE
Bhoomi D Patel, Hitesh J Vekaria
Central composite design based RP-HPLC method optimization for the synchronized analysis of Efonidipine Hydrochloride Ethanolate (EFE) and Chlorthalidone (CHL) in tablet. The effective separation was performed using Inertsil ODS C18 column (250 × 4.6 mm, 5 μm), PDA detector with 0.05 M KH2PO4 Buffer (pH 4.5): Acetonitrile (40:60%v/v) mobile phase. Independent variables were investigated include the concentration of KH2PO4 (X1) and flow rate of mobile phase (X2). Based on responses obtained (retention time, resolution and tailing factor), the optimum condition selected was X1 = 40% and X2 = 1 ml/min...
September 23, 2023: Journal of Chromatographic Science
https://read.qxmd.com/read/37725471/chlorthalidone-no-better-than-hydrochlorothiazide-for-hypertension
#16
JOURNAL ARTICLE
Mark H Ebell
No abstract text is available yet for this article.
September 2023: American Family Physician
https://read.qxmd.com/read/37680384/novel-variant-of-slc34a3-in-a-compound-heterozygous-brazilian-girl-with-hereditary-hypophosphatemic-rickets-with-hypercalciuria
#17
JOURNAL ARTICLE
Luciana Pinto Valadares, Daniel Rocha de Carvalho
Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare FGF23-independent disorder caused by biallelic variants in the SLC34A3 gene. The disease severity varies, and patients have an increased risk of developing renal complications. Phosphate supplementation is standard of care and active vitamin D analogs are not indicated as they could worsen the hypercalciuria. We report a Brazilian girl with HHRH who presented with knee pain and progressive genu valgum deformity that became apparent later in childhood (at age 8)...
September 8, 2023: Journal of Clinical Research in Pediatric Endocrinology
https://read.qxmd.com/read/37614053/efficacy-and-safety-of-standard-dose-triple-combination-of-telmisartan-80%C3%A2-mg-amlodipine-5%C3%A2-mg-chlorthalidone-25%C3%A2-mg-in-primary-hypertension-a-randomized-double-blind-active-controlled-multicenter-phase-3-trial
#18
JOURNAL ARTICLE
Eun Joo Cho, Moo Hyun Kim, Young-Hak Kim, Kiyuk Chang, Dong-Ju Choi, Woong Chol Kang, Jinho Shin, Seong Hwan Kim, Namho Lee, Jang Won Son, Joon-Hyung Doh, Woo-Shik Kim, Soon Jun Hong, Moo-Yong Rhee, Youngkeun Ahn, Sang-Wook Lim, Seung Pyo Hong, So-Yeon Choi, Min Su Hyon, Jin-Yong Hwang, Kihwan Kwon, Kwang Soo Cha, Sang-Hyun Ihm, Jae-Hwan Lee, Byung-Su Yoo, Hyo-Soo Kim
The authors evaluated the efficacy, safety, and characteristics of patients who respond well to standard dose triple combination therapy including chlorthalidone 25 mg with telmisartan 80 mg plus amlodipine 5 mg in hypertensive patients. This is a multicenter, double-blind, active-controlled, phase 3, randomized trial. Patients are randomized to triple combination (telmisartan 40 mg/amlodipine 5 mg/chlorthalidone 12.5 mg, TEL/AML/CHTD group) or dual combination (telmisartan 40 mg/amlodipine 5 mg, TEL/AML group) treatment and then dose up titration to TEL 80/AML5/CHTD25mg and TEL80/AML5, respectively...
August 23, 2023: Journal of Clinical Hypertension
https://read.qxmd.com/read/37599478/development-and-validation-of-rp-hplc-method-for-the-simultaneous-determination-of-azilsartan-medoxomil-and-chlorthalidone-in-solid-dosage-form
#19
JOURNAL ARTICLE
- Muhammad Jahangir, - Arooj Azhar, - Aymen Awan
The fixed dose combination of azilsartan medoxomil and chlorthalidone has been effectively used to treat hypertension. Development of a specific and accurate Reverse-Phase HPLC method for simultaneous estimation of AZL and CLR was main objective of this study that was used for simultaneous quantification of these drugs in human plasma. The method used 30:70 acetonitrile and water as mobile phase, thermo-scientific ODS hypersil C18 column (250 × 4.6 mm, 5µm),1.2mL/min flow rate analyzed at 230nm. The retention time was 1...
July 2023: Pakistan Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/37565307/pharmacological-interventions-for-asymptomatic-carotid-stenosis
#20
REVIEW
Caroline Nb Clezar, Carolina Dq Flumignan, Nicolle Cassola, Luis Cu Nakano, Virginia Fm Trevisani, Ronald Lg Flumignan
BACKGROUND: Carotid artery stenosis is narrowing of the carotid arteries. Asymptomatic carotid stenosis is when this narrowing occurs in people without a history or symptoms of this disease. It is caused by atherosclerosis; that is, the build-up of fats, cholesterol, and other substances in and on the artery walls. Atherosclerosis is more likely to occur in people with several risk factors, such as diabetes, hypertension, hyperlipidaemia, and smoking. As this damage can develop without symptoms, the first symptom can be a fatal or disabling stroke, known as ischaemic stroke...
August 4, 2023: Cochrane Database of Systematic Reviews
keyword
keyword
13168
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.